Capital increase to accelerate go-to-market and drive international growth

Delft, The Netherlands – Bluebee, a pioneer in cloud-based high performance genomics solutions, today announced the closing of its Series A round of venture capital funding. The company raised €10 million ($11.6 million) from a strategic group of investors active at the crossroads of life sciences and ICT, including Capricorn ICT Arkiv, Korys and Biover II.

The financing was subscribed by Bluebee’s existing shareholders, including Buysse & Partners and the management team. The investment will support ongoing innovation of the Bluebee platform, a unique cloud-based accelerated genomics analysis solution to enable fast, efficient and affordable processing of large volumes of genomics data.

Bluebee’s technology allows research centres, clinical labs and diagnostics companies to substantially reduce cost, complexity and throughput time of their genomic data analysis. “Our technology solves one of the biggest bottlenecks in DNA analysis today,” says Hans Cobben, CEO of Bluebee, “the solution has been designed to accelerate scientific and clinical breakthroughs, to simplify collaboration amongst scientists and to facilitate global roll-out of genetic tests.”

Founded in 2011 by Prof. dr. ir. Koen Bertels as a spin-off of the Delft University of Technology and Imperial College London, Bluebee uniquely offers a cloud-based, distributed computing solution combined with accelerated hardware. This allows mass sequencing data volumes to be processed in extremely short timeframes while respecting gold standard algorithms.

For further reading, please go to http://www.capricorn.be/en/news